The current study represents a pioneering effort in this domain, to elucidate no significant disparities in the levels of BDNF, proBDNF, GDNF, NTF3, and NTF4 between OSA patients and control subjects, evaluated both at the protein and mRNA expression levels. This evidence concerns the gene GDNF and obstructive sleep apnea syndrome.